Literature DB >> 10996828

Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.

P Angchaisuksiri1, S Pingsuthiwong, K Aryuchai, M Busabaratana, T Sura, V Atichartakarn, P Sritara.   

Abstract

We investigated the prevalence of a genetic variation in the factor V gene (G1691A Leiden mutation) and the prothrombin gene (G20210A) using polymerase chain reaction techniques in samples from 500 normal Thai population and among 50 unselected Thai patients with an objectively confirmed history of deep venous thrombosis. The prevalence of factor V Leiden and the prothrombin G20210A gene mutation in a group of 500 healthy controls was 0.2% in both groups (allele frequency of 0.1%). Of the 50 adult patients studied, none was a carrier of factor V Leiden or the prothrombin G20210A gene mutation. Our findings confirm that the prevalence of factor V Leiden and prothrombin G20210A gene mutation is lower among Asians than Caucasians and that the distribution of factor V Leiden is similar to that of the prothrombin G20210A variant. The low prevalence of these two mutations can, at least in part, account for the lower frequency of deep venous thrombosis reported in the Thai population. Screening for factor V Leiden and prothrombin gene mutation is of limited benefit and may not be cost-effective in Thai patients with the first episode of deep venous thrombosis. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996828     DOI: 10.1002/1096-8652(200010)65:2<119::aid-ajh5>3.0.co;2-8

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach.

Authors:  Amira S Sabbagh; Georges Ibrahim; Ziad Kanaan; Dina M R Shammaa; Rabab Abdel Khalek; Mona Ghasham; Layal Greige; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-12-08       Impact factor: 2.316

2.  Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Hadi Mozafari; Hadi Kharrazi; Mansour Rezaei; Ronald L Nagel
Journal:  J Thromb Thrombolysis       Date:  2007-08-14       Impact factor: 2.300

3.  Evaluation of the efficacy of venous thromboembolism prophylaxis guideline implementation in Japan.

Authors:  Kiyoaki Niimi; Masayoshi Kobayashi; Hiroshi Narita; Kiyohito Yamamoto; Kimihiro Komori
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

4.  Clinical Manifestations and Prognostic Factors of Pulmonary Embolism in Adult Patients Visiting the Emergency Department: A Single Institute Experience.

Authors:  Hung-Chun Chung; Ching-Ching Lee; Yu-Hua Lin
Journal:  J Acute Med       Date:  2019-03-01

5.  Predictive risk factors for venous thromboembolism in neurosurgical patients: A retrospective analysis single center cohort study.

Authors:  Porntip Parmontree; Phanuwat Ketprathum; Teeraphat Ladnok; Supanut Meeaium; Thanyaras Thanaratsiriworakul; Ukrit Sonhorm
Journal:  Ann Med Surg (Lond)       Date:  2022-04-14

6.  Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population.

Authors:  Jun-Dong Chang; Mina Hur; Sang-Soo Lee; Je-Hyun Yoo; Kyu Man Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

7.  Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.

Authors:  Rana Dajani; Raja Fatahallah; Abdelrahman Dajani; Mohammad Al-Shboul; Yousef Khader
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

8.  Risk factors of venous thromboembolism in thai patients.

Authors:  Pantep Angchaisuksiri; Vichai Atichartakarn; Katcharin Aryurachai; Napaporn Archararit; Buppa Rachakom; Kanlayanee Atamasirikul; Arjit Tiraganjana
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

9.  Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults.

Authors:  Ehsan Kheradmand; Meraj Pourhossein; Gilda Amini; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2014-02-28

10.  Prevalence of thrombophilic gene polymorphisms in an azari population of iran.

Authors:  Nasrin Bargahi; Malak Farajzadeh; Ahmad Poursadegh-Zonouzi; Davoud Farajzadeh
Journal:  Hematol Rep       Date:  2014-04-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.